Celularity (CELUW) Retained Earnings (2018 - 2025)
Celularity (CELUW) reported Retained Earnings of -$991.5 million for Q4 2025, down 19829560.0% year-over-year from N/an in Q4 2024, and down 2.52% quarter-over-quarter from -$967.1 million in Q3 2025.
Celularity (CELUW) Retained Earnings (2018 - 2025) Analysis & Trends
Celularity (CELUW) has 8 years of Retained Earnings data on file, last reported at -$991.5 million in Q4 2025.
- Retained Earnings for Q4 2025 came in at -$991.5 million, down 19829560.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$991.5 million (down 19829560.0% YoY), and the FY2025 annual result was -$991.5 million, down 19829560.0% from the prior year.
- Retained Earnings declined to -$991.5 million in Q4 2025 per CELUW's latest filing, from -$967.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at $2.4 million in Q3 2023 and troughed at -$991.5 million in Q4 2025.
- A 5-year average of -$561.3 million and a median of -$672.3 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings jumped 100.36% in 2023, then sank 48354950.0% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$663.7 million in 2021, then grew by 2.74% to -$645.5 million in 2022, then plunged by 30.41% to -$841.8 million in 2023, then surged by 100.0% to -$5000.0 in 2024, then tumbled by 19829560.0% to -$991.5 million in 2025.
- Business Quant data shows CELUW's Retained Earnings at -$991.5 million in Q4 2025, -$967.1 million in Q3 2025, and -$944.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Celularity | - | - | -3.27 Mn | -991.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -991.48 Mn |
| Sep 30, 2025 | -967.10 Mn |
| Jun 30, 2025 | -944.03 Mn |
| Mar 31, 2025 | -919.50 Mn |
| Dec 31, 2024 | -5,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -870.29 Mn |
| Mar 31, 2024 | -863.80 Mn |
| Dec 31, 2023 | -841.79 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 2.39 Mn |
| Mar 31, 2023 | -709.51 Mn |
| Dec 31, 2022 | -645.50 Mn |
| Sep 30, 2022 | -669.93 Mn |
| Jun 30, 2022 | -674.73 Mn |
| Mar 31, 2022 | -722.55 Mn |
| Dec 31, 2021 | -663.68 Mn |
| Sep 30, 2021 | -659.64 Mn |
| Jun 30, 2021 | -47.41 Mn |
| Mar 31, 2021 | -39.58 Mn |